Kenneth Rictor
Family Medicine · Scotland, PANPI 1992773964
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 20.2% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $348, 5.3 times the $66 reported in 2019.
Across 63 payments — averaging $16.08 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$205
- Pfizer$170
- AbbVie$145
- Lilly USA, LLC$103
- E.r. Squibb & Sons, L.L.C.$101
- AstraZeneca$87
- plus $204 from 9 others
Across 52 payments — averaging $2292.35 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$101K
- Purdue Pharma L.p.$18K
What the payments were for
- Food & beverage$1,013100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 12 | $205 |
| Pfizer | 10 | $170 |
| AbbVie(2 entities) | 9 | $145 |
| Lilly USA, LLC | 6 | $103 |
| E.r. Squibb & Sons, L.L.C. | 7 | $101 |
| AstraZeneca | 6 | $87 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $51 |
| GSK | 3 | $47 |
| Exact Sciences | 1 | $22 |
| Radius Health, Inc. | 1 | $19 |
| Amgen | 1 | $15 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $13 |
| Bardy Diagnostics, Inc. | 1 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
| Merck | 1 | $11 |
How this compares
$1,013 in reported general payments places this provider in the 70th percentile of 4,967 family medicine providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 67 | $57,457 |
| OzempicSemaglutide | 24 | $22,315 |
| XareltoRivaroxaban | 12 | $6,695 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $6,161 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 63 | $2,964 |
| JanuviaSitagliptin Phosphate | 13 | $2,232 |
| Oxycodone Hcl | 64 | $1,824 |
| SynthroidLevothyroxine Sodium | 11 | $950 |
| Valsartan | 14 | $869 |
| Rosuvastatin Calcium | 22 | $715 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 14 | $706 |
| Metoprolol Succinate | 30 | $684 |
| Pantoprazole Sodium | 31 | $609 |
| Simvastatin | 52 | $606 |
| Levothyroxine Sodium | 73 | $604 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $170 | $57,45767 claims |
| Novo NordiskOzempic | $205 | $22,31524 claims |
| GSKTrelegy Ellipta | $47 | $6,16111 claims |
| MerckJanuvia | $11 | $2,23213 claims |
| AbbVieSynthroid | $145 | $95011 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 4,967 family medicine providers in Pennsylvania.
Other family medicine in Scotland
- Neil SkolnikJenkintown$904K
- Lisa EspinozaNew Hope$722K
- Christopher Varacallodu Bois$627K
- Paul DoghramjiCollegeville$617K
- Brian DeyarminBethel Park$491K
- Nathan BennettPittsburgh$465K
- Gary OwensGlen Mills$404K
- Mary ZakutneyIrwin$393K
- H WilkinsSellersville$380K
- Deborah WittPhiladelphia$226K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.